BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16550395)

  • 1. CD10+ stromal cells in fibroadenomas and phyllodes tumors of the breast.
    Zamecnik M; Kinkor Z; Chlumska A
    Virchows Arch; 2006 Jun; 448(6):871-2. PubMed ID: 16550395
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
    Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
    Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
    Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
    J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
    Maritz RM; Michelow PM
    Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign phyllodes tumour vs fibroadenoma: FNA cytological differentiation.
    Veneti S; Manek S
    Cytopathology; 2001 Oct; 12(5):321-8. PubMed ID: 11722512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
    Tsai WC; Jin JS; Yu JC; Sheu LF
    Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phyllodes tumors and fibroadenoma common beginning and different ending.
    Oprić S; Oprić D; Gugić D; Granić M
    Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
    Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
    Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
    Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
    Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
    Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular (juvenile) fibroadenoma of the breast. A clinico-pathologic and immunohistochemical study of 7 cases].
    Remadi S; Ismail A; Karpuz V; Finci V; Zacharie S; Vassilakos P
    Ann Pathol; 1994; 14(6):392-7. PubMed ID: 7857414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
    Bode MK; Rissanen T; Apaja-Sarkkinen M
    Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Tamsen A
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinucleated giant cells in a breast fine needle aspirate.
    Ho C; Duggan MA
    Cytopathology; 2002 Aug; 13(4):247-53. PubMed ID: 12269898
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytological Findings in Benign Phyllodes Tumors.
    Kumar PV; Mokhtari M
    Acta Cytol; 2019; 63(1):23-27. PubMed ID: 30368498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
    Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
    Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical appraisal of stromal CD10 staining in fibroepithelial lesions of breast with a special emphasis on expression patterns and correlation with WHO grading.
    Puri V; Jain M; Mahajan G; Pujani M
    J Cancer Res Ther; 2016; 12(2):667-70. PubMed ID: 27461629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cytologic features of fibroepithelial lesions of the breast.
    Deen SA; McKee GT; Kissin MW
    Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.
    Umekita Y; Yoshida H
    Pathol Int; 1999 Sep; 49(9):807-10. PubMed ID: 10504552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.